The Gosnold Innovation Center


Dedicated to Improving Addiction Prevention, Treatment, and Management

Throughout our history we have established leading-edge programs and services that have been recognized regionally and nationally.  Our commitment to improve addiction treatment has led to the creation of a dedicated unit to focus on innovation and research.  Led by former President and CEO, Raymond Tamasi, the Gosnold Innovation Center is developing and testing innovative treatment methods, progressive prevention programs, and effective recovery management services.  And, our ideas and vision are consistent with those articulated by the Surgeon General of the United States.  His report, “Facing Addiction in America” identified five major components of a comprehensive approach to address substance use disorders including:

1) Enhanced public education to improve awareness about substance use problems and more effective policies and practices to address them;
2) Implementation of evidence-based prevention policies and programs to prevent substance misuse and related harms;
3) Improved access to evidence-based services, integrated with mainstream health care, for those at risk for or affected by substance use disorders;
4) Recovery support services (RSS) to assist individuals in maintaining remission and preventing relapse;
5) Research-informed public policies and financing strategies to ensure that substance misuse and use disorder services are accessible, compassionate, efficient, and sustainable.


Integration With Medical Providers

The best way to addiction severity is to identify risk and intervene before more serious symptoms appear.  Gosnold clinicians, embedded in physician practices enables this early identification, and provides the opportunity for clinical interventions and patient education.  Because it occurs in concert with the patient’s medical provider it ensures seamless care of both physical and mental health.

Projects currently in pilot stages:

On-Line Treatment–A project undertaken with PEAR Therapeutics seeks to assess the value and utility of psycho-social education provided directly through a mobile device that patients can access any time, any place.  We want to learn how patients respond to this approach and if it helps them when they aren’t meeting face to face with their therapist.

Medication Adherence–Recognizing the failure to take medication as prescribed is a leading cause of re-hospitalization, this innovation uses a technology enhanced medication dispensing system to remind patients of dosing times and it communicates this information to their prescriber.

Incentive Based Recovery–Using remote drug testing technology, this approach rewards patients who maintain fidelity to counseling appointments, recovery support group attendance, and negative drug tests.  Patient success enables them to accumulate rewards that convert to debit card credits that can only be used for recovery related purchases.

Raymond V Tamasi

Raymond V. Tamasi has over 40 years of experience managing treatment, intervention, and prevention services.  For 25 of those years he was Gosnold’s President/CEO and during his tenure Gosnold developed an array of clinical services that merited national recognition.  He currently serves as the President and Founder of the Gosnold Innovation Center, focusing on the development of innovative approaches for addiction treatment, prevention, and medical integration.

Mr. Tamasi has been recognized nationally and is a frequent speaker on issues of policy and the redefining of the addiction treatment and prevention system.  Mr. Tamasi was a member of Governor Charlie Baker’s Opioid Working Group and in 2017, the Governor appointed him to the Special Commission on Behavioral Health and Prevention.  Mr. Tamasi has a Bachelor’s of Arts in Economics and a Masters of Education with a concentration in Counseling and Healthcare Administration.